Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,368.85
(
-1.67%
)
US TECH 100
22,405.20
(
-2.38%
)
Dow Jones
45,166.64
(
-1.73%
)
Brent Oil
106.89
(
0.00%
)
Bitcoin
66,759.10
(
0.64%
)
News Focus
News Focus

Replies to post #213005 on Biotech Values

Replies to #213005 on Biotech Values
icon url

DewDiligence

09/18/18 1:57 PM

#220931 RE: DewDiligence #213005

ZEAL +9% on phase-3 hypoglycemia results:

https://globenewswire.com/news-release/2018/09/18/1572374/0/en/Zealand-Pharma-achieves-primary-and-key-secondary-endpoints-in-pivotal-Phase-3-trial-with-dasiglucagon-for-severe-hypoglycemia.html